News
ICViewExpert PerspectivesMedical World NewsVideosWebinars
Conference CoverageConference ListingAPIC Chapters
Infection Control TodaySupplements And Featured Publications
CME/CEEditorial Advisory BoardJob BoardPartnersSponsoredWhitepapers
Subscribe
Educator of the Year Official Rules2024 Educator of the Year Winner2023 Educator of the Year WinnerEducator of the Year
Advanced TechnologyAdvanced TechnologyAdvanced Technology
Bug of the Month
COVID-19
Environmental ServicesEnvironmental Services
HAIs
Hand Hygiene
IC Trends
Long-Term CareLong-Term Care
Operating Room
Personal Protective EquipmentPersonal Protective Equipment
Policy
PreventionPreventionPreventionPrevention
Sterile ProcessingSterile Processing
Surface Disinfection
Vascular Access
Spotlight -
  • IC Trends
  • Bug of the Month
  • Featured Articles
  • Featured Columns
  • Pathogen Playbook
Advanced TechnologyAdvanced TechnologyAdvanced Technology
Bug of the Month
COVID-19
Environmental ServicesEnvironmental Services
HAIs
Hand Hygiene
IC Trends
Long-Term CareLong-Term Care
Operating Room
Personal Protective EquipmentPersonal Protective Equipment
Policy
PreventionPreventionPreventionPrevention
Sterile ProcessingSterile Processing
Surface Disinfection
Vascular Access
    • News
    • Subscribe
Advertisement

First Large Clinical Trial of Flu Vaccines Designed to Prevent Heart and Lung-Related Illness Begins

September 28, 2016
Article

Heart disease patients enrolled in a clinical trial -- designed to test whether a stronger dose of the influenza vaccine can prevent death or hospitalization due to a heart attack, heart failure, stroke or pneumonia -- have begun receiving their first flu shots in Toronto and Boston.

Spearheaded by researchers from the Peter Munk Cardiac Centre, University Health Network (UHN) and Women’s College Hospital, this first, large-scale North American study is a collaboration of numerous healthcare centres in Canada and the United States that are taking part in the Influenza Vaccine to Effectively Stop Cardio Thoracic Events and Decompensated Heart Failure (INVESTED) trial. This trial is supported by the National Heart, Lung and Blood Institute (NHLBI) of the National Institutes of Health (NIH).

“As the Canadian leaders in this extensive study, our multi-disciplinary team of cardiac and vascular scientists, researchers and global clinical trials specialists are poised to potentially alter how this large group of already-susceptible heart patients is managed,” says Dr. Barry Rubin, medical director of the Peter Munk Cardiac Centre at UHN.

“An investigation of this scope that is focused on testing a potential new approach to prevent deteriorating health or death in heart failure and heart attack patients is significant,” he says.

Supported by a $21 million grant from the NIH, INVESTED will test the efficacy of two different formulations of the influenza vaccine --- the standard dose and a stronger dose --- in patients with heart failure or patients who have had a heart attack in the previous year. The test will determine which vaccine better protects these patients from having their heart and lung conditions worsen so that they require hospital admission, or become fatal.

“Research has shown that the standard flu vaccine may prevent heart attacks but it does not provide enough of an immune boost or protection for patients with a cardiac condition,” says Dr. Jacob Udell, cardiologist, Peter Munk Cardiac Centre and Women’s College Hospital, Assistant Professor of Medicine, University of Toronto, and one of the Canadian co-Principal Investigators in INVESTED.

“Given that more heart disease patients die as a result of the flu than any other chronic health condition, and that the standard flu vaccine has been found to reduce the risk of heart attack in these patients, perhaps a stronger dose flu vaccine could provide even greater benefit and now is the time to definitively answer this question” he says.

Over the next four flu seasons, some 9,000 patients will be enrolled in INVESTED across 180 clinics and hospitals across North America.

“If successful, the public health impact could be substantial," says Dr. Scott Solomon, a cardiologist at Boston’s Brigham and Women’s Hospital and a Harvard Medical School professor, and one of the American co-principal investigators in the trial.

Influenza kills about 3,500 Canadians and 36,000 Americans, each year.

Source Newsroom: University Health Network (UHN)

Recent Videos
Concept images of Far-UVC  (Adobe Stock 316993517 by hopenv)
Physicians Sound Alarm: Vaccine Misinformation and Policy Failures Threaten US Public Health
Anna Castillo-Gutierrez, CRCST, CSPDT, CHL, CIS, CFER,  and Maya Luera, CRCST, CIS, CER, CHL
Lucy Witt, MD
Chase Elms, BS, CRCST
Garrett Hollembeak, CRCST, CIS, CHL, CER, CIC
Hannah Schroeder, BSHA, CRCST, CIS, CHL, CER,
Anthony Bondon CRCST, CHL, BSM, AAS, SME, LSSYB
Deannard Esnard, CRCST, CIS, CER, CHL, CFER, CQUIA
Kevin Bush, Jr, DHSc, EdD, MSHA, MA, MS, FACHE
Related Content

Concept photo of a hospital worker doing cleaning in operation room  (Adobe Stock 248152636 by karrastock)

Optimizing Training for Environmental Services Staff: A Critical Component of Patient Safety and Infection Control

Tommy Davis, PhD
May 15th 2025
Article

A determined infection preventionist is walking into a busy facility.  (AI image created by author)

IP LifeLine: Resilience as an Ongoing Journey, Not a Destination

Brenna Doran, PhD, MA, ACC, CIC
May 15th 2025
Article

As infection prevention infrastructure unravels, professionals face déjà vu from the pandemic’s darkest days—making resilience not just important, but essential for survival and progress.


Simone Godwin, DVM, MPH, CIC

Non-tuberculous Mycobacterium Outbreak at Surgery Center Highlights Infection Control Lapses

Alexander Sundermann, DrPH, CIC, FAPIC
May 13th 2025
Article

A rare Tennessee outbreak of Mycobacterium fortuitum revealed deep gaps in infection prevention at outpatient surgery centers—where oversight, staffing, and reporting often fall short.


The disbanding of HICPAC  (Adobe Stock)

In the Wake of HICPAC: How APIC is Leading the Fight to Preserve National Infection Prevention Standards

Tori Whitacre Martonicz
May 13th 2025
Article

The disbanding of HICPAC has left infection prevention experts scrambling to preserve national standards and ensure continuity amid growing concern over science-driven public health policy. Connie Steed, MSN, RN, CIC, FAPIC, speaks with ICT.


Hot Topics in Infection Prevention With Saskia v. Popescu

Hot Topics in IPC for May 9, 2025: HICPAC, Measles, H5N1, and More

Saskia v. Popescu, PhD, MPH, MA, CIC, FAPIC
May 9th 2025
Article

This week’s Infection Control Today’s Hot Topics in IPC discusses the latest in the measles outbreak, H5N1 in cattle herds, HICPAC, and more.


CDC: HICPAC Silenced  (Adobe Stock)

The Disbanding of HICPAC: A Dangerous Silencing in the Fight Against Health Care-Associated Infections

Heather Stoltzfus, MPH, RN, CIC
May 8th 2025
Article

The abrupt disbanding of HICPAC silences decades of infection control expertise, leaving health care workers without unified guidance as deadly threats to patient safety rise.

Related Content

Concept photo of a hospital worker doing cleaning in operation room  (Adobe Stock 248152636 by karrastock)

Optimizing Training for Environmental Services Staff: A Critical Component of Patient Safety and Infection Control

Tommy Davis, PhD
May 15th 2025
Article

A determined infection preventionist is walking into a busy facility.  (AI image created by author)

IP LifeLine: Resilience as an Ongoing Journey, Not a Destination

Brenna Doran, PhD, MA, ACC, CIC
May 15th 2025
Article

As infection prevention infrastructure unravels, professionals face déjà vu from the pandemic’s darkest days—making resilience not just important, but essential for survival and progress.


Simone Godwin, DVM, MPH, CIC

Non-tuberculous Mycobacterium Outbreak at Surgery Center Highlights Infection Control Lapses

Alexander Sundermann, DrPH, CIC, FAPIC
May 13th 2025
Article

A rare Tennessee outbreak of Mycobacterium fortuitum revealed deep gaps in infection prevention at outpatient surgery centers—where oversight, staffing, and reporting often fall short.


The disbanding of HICPAC  (Adobe Stock)

In the Wake of HICPAC: How APIC is Leading the Fight to Preserve National Infection Prevention Standards

Tori Whitacre Martonicz
May 13th 2025
Article

The disbanding of HICPAC has left infection prevention experts scrambling to preserve national standards and ensure continuity amid growing concern over science-driven public health policy. Connie Steed, MSN, RN, CIC, FAPIC, speaks with ICT.


Hot Topics in Infection Prevention With Saskia v. Popescu

Hot Topics in IPC for May 9, 2025: HICPAC, Measles, H5N1, and More

Saskia v. Popescu, PhD, MPH, MA, CIC, FAPIC
May 9th 2025
Article

This week’s Infection Control Today’s Hot Topics in IPC discusses the latest in the measles outbreak, H5N1 in cattle herds, HICPAC, and more.


CDC: HICPAC Silenced  (Adobe Stock)

The Disbanding of HICPAC: A Dangerous Silencing in the Fight Against Health Care-Associated Infections

Heather Stoltzfus, MPH, RN, CIC
May 8th 2025
Article

The abrupt disbanding of HICPAC silences decades of infection control expertise, leaving health care workers without unified guidance as deadly threats to patient safety rise.

Advertise
About Us
Editorial Board
Contact Us
Job Board
Terms and Conditions
Privacy
Do Not Sell My Personal Information
Contact Info

2 Commerce Drive
Cranbury, NJ 08512

609-716-7777

© 2025 MJH Life Sciences

All rights reserved.
Home
About Us
News